In 2023, the global carrier screening market reached a value of $1.9 billion, and it is anticipated by IMARC Group to grow to $4.4 billion by 2032, with a projected CAGR of 9.7% from 2024 to 2032. This growth is primarily fueled by ongoing advancements in genetic technology, increased awareness and demand for early detection of genetic disorders, supportive government initiatives, a rising prevalence of genetic disorders, the expansion of newborn screening programs, and the growing adoption of personalized medicine. Visit us: https://www.imarcgroup.com/car....rier-screening-marke
Like
Comment
Share
